Status:
COMPLETED
Reduction of Microemboli of Air Using a New Developed Air Trap (EmbolessTM) During Haemodialysis
Lead Sponsor:
Umeå University
Conditions:
Hemodialysis Complication
Air Embolism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During hemodialysis (HD) the blood of the patient pass an extracorporeal circuit that contains a dialyzer for rinsing and a venous chamber (air trap) to prevent from air embolism through the return bl...
Detailed Description
During hemodialysis (HD) the blood of the patient pass an extracorporeal circuit that contains a dialyzer for rinsing and a venous chamber (air trap) to prevent from air embolism through the return bl...
Eligibility Criteria
Inclusion
- Accepted are all patients performing chronic HD due to End Stage renal disease of any reason:
- 18 years and older
- accept, by consent, to participate in the study
- both genders,
- any ethnicity
Exclusion
- Patients that are expected not to fulfil a whole series of two dialysis within the study such as those:
- who suffer from active cancer or severe infection, cachexia or are planned for kidney transplantation close to the study period.
- patients that by any reason are considered inappropriate by the principal investigator, such as patients that experience severe hypotensive episodes during standard dialysis.
- Home-haemodialysis treatments and self-care dialysis treatments are not included in the study. If such patient accepts to participate in the study, he/she has to adapt to study criteria (assisted treatment).
Key Trial Info
Start Date :
May 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06168539
Start Date
May 11 2022
End Date
December 10 2024
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Region Vasterbotten, Skelleftea Sjukhus, Dialysen
Skellefteå, Sweden